Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.
Han S; Hagan DL; Taylor JR; Xin L; Meng W; Biller SA; Wetterau JR; Washburn WN; Whaley JM; Diabetes, 2008, vol. 57, issue 6, p 1723, ISSN 1939327x. ISBN 1939327x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef